|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Randomized phase Ⅲ trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer显示文摘 | Reynolds C Obasaju C Schell MJ | 2009 | J Clin Oncol2009，27，34： | 1 |
| 2 | Preliminary indication of sur- vival benefit from ERCC1 and RRM1 - tailored chemotherapy in pa- tients with advanced nonsmall cell lung cancer: Evidence from an in- dividual patient analysis显示文摘 | Simon GR Schell MJ Begum M | 2012 | cancer2012，118，9： | 1 |
| 3 | The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced stage Ⅲb or Ⅳ nonsmall cell lung carcinoma treated with carboplatin and paclitaxel显示文摘 | Hensing TA Peterman AH Schell MJ | 2003 | Cancer2003，98，4： | 1 |
| 4 | Phase Ⅲ trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage Ⅲ B/Ⅳ non-small-cell lung cancer显示文摘 | Socinski MA Schell MJ Peterman A | | 0，，05： | 1 |
| 5 | Randomized phase ill trial of gemcitabine-based chemotherapy with in situ RRM I and ERCC I protein levels for response predic?tion in non-small-cell lung cancer显示文摘 | Reynolds C Obasaju C Schell MJ | 2009 | J Clin Oncol2009，27，34： | 1 |
| 6 | Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer显示文摘 | Titus MA Schell MJ Lih FB | 2005 | Clin Cancer Res2005，11，： | 1 |
| 7 | Complications and out come in childhood acute lymphoblastic leukemia with hyperleuko cytosis显示文摘 | Egiguren JM Schell MJ Crist WM | 1992 | Blood1992，79，： | 1 |
| 8 | A randomized, double blind, phase Ⅲtrial using oral beta - carotene supplementation for women with high - grade cervical intraepithelial neoplasia显示文摘 | Keefe KA Schell MJ Brewer C | 2001 | Cancer Epidemiol Biomarkers Prev2001，10，10： | 1 |
| 9 | Randomized international phase II1 trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non- small-cell lung cancer显示文摘 | Bepler G Williams C Schell MJ | 2013 | J Clin Oncol2013，31，19： | 1 |
| 10 | The impact of age on toxicity,response rate,quality of life,and survival in patients with advanced stage Ⅲb or Ⅳ non-small cell lung carcinoma treated with carboplatin and paclitaxel显示文摘 | Hensing TA Peterman AH Schell MJ | 2003 | Cancer2003，98，4： | 1 |
| 11 | Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjects 显示文摘 | Relling MV Cherrie J Schell MJ | 1991 | Clin Pharmacol Ther1991，50，： | 1 |
| 12 | Phase HI trial comparing a defined duration of therapy versus continu- ous therapy followed by second-line therapy in ad- vance&stage IlI B-IV non-small-cell lung cancer显示文摘 | Socinski MA Schell MJ Peteman A | 2002 | J Clin Oncol2002，20，5： | 1 |
| 13 | Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer显示文摘 | Bepler G Williams C Schell MJ | 2013 | J Clin Oncol2013，31，19： | 1 |
| 14 | Randomized phase 111 trial of Gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer显示文摘 | Reynolds C Obasaju C Schell MJ | 2009 | J Clin Oncol2009，27，34： | 1 |
| 15 | Testosterone and di- hydrotestosterone tissue levels in recurrent prostate cancer 显示文摘 | Titus MA Schell MJ Lih FB | 2005 | Clin Cancer Res2005，11，13： | 1 |
| 16 | Outcomesofadrenalectomy- forisolated synchronous venus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis 显示文摘 | Tanvetyanon T Robinson LA Schell MJ | 2008 | J Clin Oncol2008，26，7： | 1 |
| 17 | Outcomesof adrenalectomy for isolated synchronous versusmetachronous adrenal metastases in non-small*cel] lungcancer:a systematic review and pooled analysis 显示文摘 | Tanvetyanon T Robinson LA Schell MJ | 2008 | J ClinOncol2008，26，7： | 1 |
| 18 | Randomized phase Ⅲ trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lungcancer显示文摘 | Reynolds C Obasaju C Schell MJ | 2009 | J Clin Oncol2009，27，34： | 1 |
| 19 | Outcomes of adrena-lectomy for isolated synchronous versus metachronous adrenal metas-tases in non-small-cell lung cancer ? a systematic review and pooled a-nalysis显示文摘 | Tanvetyanon T Robinson LA Schell MJ | 2008 | J Clin Oncol2008，26，7： | 1 |
| 20 | Second-line,low-dose,weekly paclitaxel in patients with stage ⅢB/Ⅳ non small cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel显示文摘 | Socinski MA Schell MJ Bakri K | 2002 | Cancer2002，95，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员